Efficiency of 1-year treatment with fluvastatin in hyperlipidemic patients with Nephrotic syndrome

American Journal of Nephrology

Volumn 19, Issue 4, 1999, Pages 492-494

  Matzkies, Fritz K ^a   Bahner, Udo ^b   Teschner, Markus ^b   Hohage, H ^a   Heidland, August ^b   Schaefer, Roland M ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Dialysis Center   (Germany)

Author keywords

Cholesterol; Fluvastatin; Hyperlipidemia; Lipoprotein Lp(a); Nephrotic syndrome; Triglyceride

Indexed keywords

CHOLESTEROL; CREATININE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN METABOLISM; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; CHOLESTEROL; FATTY ACIDS, MONOUNSATURATED; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; INDOLES; NEPHROTIC SYNDROME; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032788351     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000013504     Document Type: Article

References (11)

1. Joven J, Villabona C, Vilella E, Masana L, Alberti R, Valles M: Abnormalities of lipoprotein metabolism in patients with nephrotic syndrome. N Engl J Med 1990;323:579-584.
2. Mallick NP, Short CD: The nephrotic syndrome and ischaemic heart disease. Nephron 1981;27:54-57.
3. Moorhead JF, Chan Mk, El Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;ii:1309-1311.
4. Schmitz PG, Kasiske BL, O'Donnell MP, Keane WF: Lipids and progressive renal injury. Semin Nephrol 1989;9:354-369.
5. Biesenbach G, Zazgornik J: Lovastatin in the treatment of hypercholesterolemia in nephrotic syndrome due to diabetic nephropathy stage IV-V. Clin Nephrol 1992;37:274-279.
6. Wanner C, Böhler J, Eckardt HG, Wieland H, Schollmeyer P: Effects of simvastatin on lipoprotein (a) and lipoprotein composition in patients with nephrotic syndrome. Clin Nephrol 1994;41:138-143.
7. Tse FL, Jaffe JM, Troendle A: Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers. J Clin Pharmacol 1992; 32:630-638.
8. Friedewald WT, Levy RJ, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
9. Short CD, Durrington PN, Mallick NP, Bathnagar D, Hunt LP, M'Bewu A: Serum lipoprotein(a) in men with proteinuria due to idiopathic membranous nephropathy. Nephrol Dial Transplant 1992;7(suppl 1):109-113.
10. Knight BL, Perombelon YF, Soutar AK, Wade DP, Seed M: Catabolism of lipoprotein (a) in familial hypercholesterolaemic subjects. Atherosclerosis 1991;87:227-237.
11. Prata MM, Nogueira AC, Pinto JR, Correia AM, Vicente O, Rodrigues MC, Miguel MJ: Long-term effect of lovastatin on lipoprotein profile in patients with primary nephrotic syndrome. Clin Nephrol 1994;41:277-283.